Journal article
Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas
Journal of oncology, Vol.2019, 5859680
06/19/2019
DOI: 10.1155/2019/5859680
PMCID: PMC6607721
PMID: 31320902
Abstract
Interleukin-1 alpha (IL-1α) is a pleiotropic cytokine involved in inflammation and immune response and is upregulated in many solid tumors including head and neck squamous cell carcinomas. Although IL-1α expression is generally associated with poor prognosis, the implications of the subcellular localization of IL-1α expression in patient outcomes are poorly understood. This study is aimed at investigating the prognostic value of nuclear and cytoplasmic immunohistochemical IL-1α expression in oral squamous cell carcinomas (OSCCs). Tissue microarrays containing 146 OSCCs were analyzed for IL-1α and epidermal growth factor receptor (EGFR) expression by immunohistochemistry. IL-1α and EGFR expression scores were correlated with clinicopathological parameters and survival outcomes. IL-1α expression was observed in the nuclear and/or cytoplasmic compartments in 98% of evaluable tumors and 78% of tumors expressed IL-1α in both compartments. There were no differences observed in overall survival or progression-free survival between high, moderate, or negative IL-1α nuclear/cytoplasmic expression scores. When IL-1α nuclear/cytoplasmic expression scores were stratified by positive or negative EGFR expression, tumors with a combined EGFR-positive and high nuclear IL-1α expression profile were significantly more likely to possess perineural invasion and were significantly associated with a high risk of tumor recurrence and worse progression-free survival compared to all other EGFR and combined IL-1α/EGFR expression profiles. Altogether, nuclear IL-1α expression may enhance the prognostic value of EGFR in OSCC and warrants further study as a prognostic biomarker for recurrence.
Details
- Title: Subtitle
- Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas
- Creators
- Anand Rajan - University of Iowa Hospitals and ClinicsKatherine N Gibson-Corley - University of Iowa Hospitals and ClinicsAllen B Choi - University of Iowa Hospitals and ClinicsGeorgina K Ofori-Amanfo - University of Iowa Hospitals and ClinicsPatrick Ten Eyck - University of Iowa Hospitals and ClinicsMadelyn Espinosa-Cotton - University of Iowa Hospitals and ClinicsSteven M Sperry - University of Iowa Hospitals and ClinicsAndrean L Simons - University of Iowa Hospitals and Clinics
- Resource Type
- Journal article
- Publication Details
- Journal of oncology, Vol.2019, 5859680
- DOI
- 10.1155/2019/5859680
- PMID
- 31320902
- PMCID
- PMC6607721
- NLM abbreviation
- J Oncol
- ISSN
- 1687-8450
- eISSN
- 1687-8450
- Grant note
- name: Department of Pathology and National Institutes of Health, award: R01DE024550, UL1TR002537
- Language
- English
- Date published
- 06/19/2019
- Academic Unit
- Oral Pathology, Radiology and Medicine; The University of Iowa Institute for Vision Research; Pathology; Pharmaceutical Sciences and Experimental Therapeutics; Biostatistics; Surgery; Radiation Oncology; Ophthalmology and Visual Sciences
- Record Identifier
- 9984186531902771
Metrics
15 Record Views